Philippines approves emergency use of Novavax COVID-19 vaccine

The Philippines Food and Drug Agency Chief Rolando Enrique Domingo said that the Novavax COVID-19 vaccine has been approved for emergency use. The vaccine will be manufactured by the Serum Institute of India under the brand name Covovax for use on adults 18 and above. It will be administered in two doses, not less than 21 days apart, he added.